| Trial ID: | L6613 |
| Source ID: | NCT01890993
|
| Associated Drug: |
Liraglutide
|
| Title: |
Retrospective Collection of Effectiveness and Safety Data From Patients Treated With Liraglutide or DPP-4 Inhibitor in Primary Care in Europe
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes|Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: liraglutide
|
| Outcome Measures: |
Primary: Change in HbA1c (glycosylated haemoglobin), Baseline (anytime within 3 months before therapy initiation), month 12 (+/-2) | Secondary: Change in body weight, Baseline (anytime within 3 months before therapy initiation), month 12 (+/-2)|Change in systolic blood pressure, Baseline (anytime within 3 months before therapy initiation), month 12 (+/-2)
|
| Sponsor/Collaborators: |
Sponsor: Novo Nordisk A/S
|
| Gender: |
ALL
|
| Age: |
CHILD, ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
952
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2013-08
|
| Completion Date: |
2014-06
|
| Results First Posted: |
|
| Last Update Posted: |
2015-05-21
|
| Locations: |
Paris La défense cedex, 92932, France|Mainz, 55127, Germany|Madrid, 28033, Spain|Crawley, RH11 9RT, United Kingdom
|
| URL: |
https://clinicaltrials.gov/show/NCT01890993
|
